Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

0 Vues· 09/01/23
The Hematologist
The Hematologist
0 Les abonnés
0
Dans

In this episode, Contributing Editor Kate Markey, MBBS, PhD, talks with Shernan Holtan, MD, one of the authors of a paper published recently in The New England Journal of Medicine: “Post-transplantation Cyclophosphamide-based Graft-versus-host Disease Prophylaxis.”

Montre plus

 0 commentaires sort   Trier par


Suivant